Compare BIO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HSIC |
|---|---|---|
| Founded | 1952 | 1932 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.3B |
| IPO Year | N/A | 1996 |
| Metric | BIO | HSIC |
|---|---|---|
| Price | $306.68 | $78.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $339.75 | $84.87 |
| AVG Volume (30 Days) | 262.7K | ★ 905.1K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | N/A | ★ 3.27 |
| Revenue | N/A | ★ $13,201,995,000.00 |
| Revenue This Year | $2.74 | $6.12 |
| Revenue Next Year | $3.20 | $3.64 |
| P/E Ratio | ★ $9.72 | $24.14 |
| Revenue Growth | N/A | ★ 5.94 |
| 52 Week Low | $211.43 | $61.97 |
| 52 Week High | $343.12 | $89.29 |
| Indicator | BIO | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 70.04 | 61.65 |
| Support Level | $293.88 | $74.15 |
| Resistance Level | $311.09 | $79.37 |
| Average True Range (ATR) | 7.49 | 1.87 |
| MACD | 3.03 | 0.63 |
| Stochastic Oscillator | 83.17 | 75.38 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.